Results 131 to 140 of about 36,230 (243)

Expanding the Phenotype of TAB2‐Related Syndrome: The First Case With Cleft Palate and Insights Into Palatal Development

open access: yes
American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1427-1430, June 2026.
Alberto De Rosa   +7 more
wiley   +1 more source

Early Outcomes of Real‐World Aortic Valve Replacement With RESILIA Tissue in the Chinese Population

open access: yesClinical Cardiology, Volume 49, Issue 6, June 2026.
In this real‐world study of 250 Chinese patients scheduled for elective aortic valve replacement, the INSPIRIS RESILIA aortic valve demonstrated favorable 1‐year safety, with a 98.0% rate of freedom from all‐cause mortality and no observed structural valve deterioration, alongside stable hemodynamic performance.
Haitao Xu   +4 more
wiley   +1 more source

An Integrated Lumped Parameter Model and Computational Fluid Dynamics Framework for Predicting Hemodynamic Parameters in Pulmonary Vein Stenosis

open access: yesComprehensive Physiology, Volume 16, Issue 3, June 2026.
This work presents a novel computational simulation framework for the study of pulmonary venous hemodynamics that integrates a closed‐loop lumped parameter model (LPM) of the cardiovascular system with a computational fluid dynamics (CFD) model of the pulmonary veins and left atrium. Coupling of the LPM and CFD models was accomplished through surrogate
Alessia Di Nardo   +3 more
wiley   +1 more source

Resistant to Ablation, Responsive to Hydroquinidine: Precision Medicine Guides Recovery in MEPPC Syndrome Cardiomyopathy

open access: yesJournal of Arrhythmia, Volume 42, Issue 3, June 2026.
We report a case of MEPPC syndrome presenting with severe dilated cardiomyopathy due to a pathogenic SCN5A p.Arg814Trp variant. Genetic diagnosis enabled precision pharmacotherapy with hydroquinidine, which suppressed multifocal Purkinje‐origin ectopy resistant to catheter ablation and led to marked improvement in left ventricular function.
Jonathan L. Ciofani   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy